Image by Getty Images via Daylife May 11, 2005 Weekly Update This morning the Energy Information Administration reported a sizable build in crude oil stocks for the third week in a row. While that has put some pressure on the price of crude oil… Read More
Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.
Analyst Articles
On Friday we doubled our margined position in Amylin Pharmaceuticals (AMLN). We were expecting fireworks in the wake of the FDA’s approval for its diabetes drug Exenatide (now Byetta). Instead, the stock received nothing short of rotten tomatoes.The only new addition to our holdings since our last weekly missive is… Read More
Image by Getty Images via Daylife Weekly Update Amylin received the approval they were seeking for Byetta with a favorable label. In addition, the FDA informed the company that they could seek the use of the drug as a stand-alone treatment, which is a… Read More
We reiterate our buy recommendation on Amylin Pharmaceuticals (AMLN). AVERAGE GAIN PER CLOSED TRADE SINCE AGGRESSIVE TRADER’S INCEPTION: 18.1% AVERAGE HOLDING PERIOD PER CLOSED TRADE: 34 days… Read More
Image by squareintheteeth via Flickr May 4, 2005 UpdateAmylin Pharmaceutical’s conference call this afternoon went a long way to clarifying investors’ misperceptions surrounding Byetta and the FDA’s labeling of the drug. The company also reinforced the market potential of the drug. And the market… Read More
This morning we rolled our position in the May 70 Schlumberger call option (SLB+EN), which is running out of time, into the longer-dated October 95 Oil Service Holders call option (OIH+JS). In the process we took a 69 percent loss on the Schlumberger call. Some of you… Read More
Image by Getty Images via Daylife Weekly Update If you took advantage of our recent recommendations to buy and sell Maytag put options, you’re probably sitting on a return of close to 207.7%. And that’s just one of many profitable trades… Read More
We closed out three trades in the past week with mixed results. Our timing on the August 120 Russell 2000 iShares put option couldn’t have been much better. We exited the trade on Monday just as the market was bottoming for a 54 percent gain. We may be entering a… Read More
Image via Wikipedia Weekly Update Big Blue recorded net income of 84 cents a share on $22.9 billion in sales. A year ago, IBM earned 81 cents a share on revenue of $22.2 billion. Wall Street, meanwhile, was looking for earnings of 90 cents a… Read More
Earlier today we sent out a note to buy the Maytag July 15 Put option (MYG+SC) at $1.50 or less. You may recall our profitable put option trade on the ailing Maytag last January. The company is perhaps worse off today, but the stock is up on a… Read More